Patents Assigned to Merck Patent Gesellschaft mit beschrankter
  • Liquid crystalline medium and liquid crystal display
    Patent number: 8262930
    Abstract: The instant invention relates to dielectrically positive nematic media comprising one, two or more compounds of formula I one or more compounds selected from the group of formulae II and III and one or more compounds selected from the group of formulae IV and V wherein the parameters are as defined in claim 1 with the proviso that the media comprise one or more compounds of formula III, wherein n and o both are 1 and all rings are 1,4-phenylene, which independently of each other optionally are fluorinated once or twice, and/or one or more compounds of formula V, wherein q is 2, as well as to liquid crystal displays comprising these media, especially to TN-displays and in particular to active matrix displays.
    Type: Grant
    Filed: March 11, 2009
    Date of Patent: September 11, 2012
    Assignee: Merck Patent Gesellschaft mit beschrankter Haftung
    Inventors: Martin (Kelun) Shu, Carol (Yi-Hsuan) Lin, Fred (Jer-Lin) Chen, Mark Verrall
  • HETEROARYLAMINOQUINOLINES AS TGF-BETA RECEPTOR KINASE INHIBITORS
    Publication number: 20120225875
    Abstract: Novel hetarylaminoquinoline derivatives of formula (I) wherein X, Z, Het, R1, R2, R3 and R4 have the meaning according to claim 1, are inhibitors of ATP consuming proteins, and can be employed, inter alia, for the treatment of tumors.
    Type: Application
    Filed: October 12, 2010
    Publication date: September 6, 2012
    Applicant: MERCK PATENT GESELLSCHAFT MIT BESCHRANKTER HAFTUNG
    Inventors: Alfred Jonczyk, Christiane Amendt, Frank Zenke
  • SM-ACTIVATED ALUMINATE AND BORATE PHOSPHORS
    Publication number: 20120224353
    Abstract: The invention relates to phosphors of the formula (I) (Ln1-a-bGdaSmb)wMgxSry(Al1-cBc)zO(3/2w+x+y+3/2z) (I) where Ln=Y, La and/or Lu a, c=0.0 to 1.0 0<b <0.2 and a+b<1.0 w=1.0 to 3.0 x, y=1.0 to 2.0 and z>0.0 to 12.0, and to a process for the preparation of these phosphors and to the use thereof as conversion phosphors for conversion of the near-UV emission from an LED.
    Type: Application
    Filed: September 15, 2010
    Publication date: September 6, 2012
    Applicant: MERCK PATENT GESELLSCHAFT MIT BESCHRANKTER HAFTUNG
    Inventors: Holger Winkler, Thomas Juestel, Simas Sakirzanovas
  • Illumination unit consisting of discharge lamp, LEDs and conversion phosphors
    Patent number: 8256920
    Abstract: The invention relates to an illumination unit having an adjustable color location consisting of a discharge lamp as primary light source and LEDs as secondary light source and additionally a phosphor layer in the form of a phosphor screen comprising conversion phosphors. Furthermore, the present invention relates to a method for lighting usable areas by the illumination unit according to the invention.
    Type: Grant
    Filed: April 18, 2008
    Date of Patent: September 4, 2012
    Assignee: Merck Patent Gesellschaft Mit Beschrankter Haftung
    Inventors: Holger Winkler, Thomas Juestel
  • PYRIDINYLIMIDAZOLONE DERIVATIVES FOR THE INHIBITION OF PI3 KINASES
    Publication number: 20120220587
    Abstract: Compounds of the formula (I), in which X1, X2, L, Y, R2, R3, R4, R5, R6, R7, R8, R9, R10 have the meanings indicated in claim 1, are PI3K inhibitors and can be employed, inter alia, for the treatment of autoimmune diseases, inflammation, cardiovascular diseases, neurodegenerative diseases and tumours.
    Type: Application
    Filed: September 6, 2010
    Publication date: August 30, 2012
    Applicant: MERCK PATENT GESELLSCHAFT MIT BESCHRANKTER HAFTUNG
    Inventors: Ulrich Emde, Hans Peter Buchstaller, Markus Klein, Christina Esdar, Joerg Bomke
  • Mesogenic dimers
    Patent number: 8252389
    Abstract: The invention relates to novel mesogenic dimeric compounds which are especially suitable for use in birefringent films with negative optical dispersion, to novel liquid crystal (LC) formulations and polymer films comprising them, and to the use of the dimers, formulations and films in optical, electrooptical, electronic, semiconducting or luminescent components or devices.
    Type: Grant
    Filed: August 29, 2008
    Date of Patent: August 28, 2012
    Assignee: Merck Patent Gesellschaft mit Beschränkter Haftung
    Inventors: Kevin Adlem, Owain Llyr Parri, Karl Skjonnemand, David Wilkes
  • PROCESS FOR THE PRODUCTION OF SOLAR CELLS COMPRISING A SELECTIVE EMITTER
    Publication number: 20120214270
    Abstract: The present invention relates to a process for the production of solar cells comprising a selective emitter using an improved etching-paste composition which has significantly improved selectivity for silicon layers
    Type: Application
    Filed: October 1, 2010
    Publication date: August 23, 2012
    Applicant: Merck Patent Gesellschaft Mit Beschrankter Haftung
    Inventors: Werner Stockum, Oliver Doll, Ingo Koehler
  • COMPOUNDS FOR A LIQUID CRYSTAL MEDIUM AND HIGH-FREQUENCY COMPONENTS CONTAINING SAID LIQUID CRYSTAL MEDIUM
    Publication number: 20120205583
    Abstract: The present invention relates to bistolans of the formula I where one or more of the radicals L1 to L3 denote an Rx, where Rx denotes cyclopropyl, cyclobutyl, cyclopentyl or cyclohexyl, and the other parameters are as defined in Claim 1. The invention also encompasses liquid-crystalline media which comprise the title compounds, to components for high-frequency technology which comprise these media, in particular phase shifters and microwave array antennae.
    Type: Application
    Filed: September 1, 2010
    Publication date: August 16, 2012
    Applicant: MERCK PATENT GESELLSCHAFT MIT BESCHRANKTER HAFTUNG
    Inventors: Elvira Montenegro, Christian Jasper, Detlef Pauluth, Volker Reiffenrath, Atsutaka Manabe
  • PYRAZOLOPYRIMIDINE DERIVATIVES
    Publication number: 20120208808
    Abstract: Compounds of the formula (I), in which X, R1 and R2 have the meanings indicated in claim 1, are PI3K inhibitors and can be employed, inter alia, for the treatment of autoimmune diseases, inflammation, cardiovascular diseases, neurodegenerative diseases and tumours.
    Type: Application
    Filed: September 24, 2010
    Publication date: August 16, 2012
    Applicant: MERCK PATENT GESELLSCHAFT MIT BESCHRANKTER HAFTUNG
    Inventors: Hans Peter Buchstaller, Ulrich Emde, Markus Klein, Christina Esdar, Joerg Bomke
  • Diazepane-acetamide derivatives as selective 11?-HSD1 inhibitors
    Patent number: 8242107
    Abstract: The present invention relates to diazepane-acetamide derivatives of formula I as selective inhibitors of the enzyme 11-beta-hydroxysteroid dehydrogenase type 1 (11?-HSD-1) and the use of such compounds for the treatment and prevention of metabolic syndrome, diabetes, insulin resistance, obesity, lipid disorders, glaucoma, osteoporosis, cognitive disorders, anxiety, depression, immune disorders, hypertension and other diseases and conditions.
    Type: Grant
    Filed: October 5, 2007
    Date of Patent: August 14, 2012
    Assignee: Merck Patent Gesellschaft Mit Beschrankter Haftung
    Inventors: Denis Carniato, Caroline Leriche, Didier Roche, Christine Charon, Liliane Doare
  • PHOSPHOR MIXTURES COMPRISING EUROPIUM-DOPED ORTHO-SILICATES
    Publication number: 20120199865
    Abstract: The invention relates to novel phosphor mixtures comprising three or more silicate phosphors. The invention furthermore relates to the use of these mixtures in electronic and electro-optical devices, in particular in light-emitting diodes (LEDs) for backlighting applications. The invention furthermore relates to LEDs comprising the phosphors.
    Type: Application
    Filed: September 10, 2010
    Publication date: August 9, 2012
    Applicant: MERCK PATENT GESELLSCHAFT MIT BESCHRANKTER HAFTUNG
    Inventors: Holger Winkler, Andreas Benker, Martina Hueber, Monika Kursawe, Ralf Petry, Stefan Tews, Tim Vosgroene
  • SULFOXIDE DERIVATIVES FOR THE TREATMENT OF TUMORS
    Publication number: 20120202827
    Abstract: Sulfoxide derivatives of the formula Ia to Im as described, and pharmaceutically usable salts, solvates, enantiomers, tautomers and stereoisomers thereof, including mixtures thereof in all ratios, for the treatment of tumours.
    Type: Application
    Filed: September 14, 2010
    Publication date: August 9, 2012
    Applicant: MERCK PATENT GESELLSCHAFT MIT BESCHRANKTER HAFUNG
    Inventors: Kai Schiemann, Melanie Schultz, Wolfgang Staehle
  • N-(pyrazole-3-yl)-benzamide derivatives as glucokinase activators
    Patent number: 8236824
    Abstract: Novel heterocyclic compounds of the formula I in which R1, R2, R3, R4, R5, R6, R7, Alk and D have the meanings indicated in claim 1, are activators of glucokinase and can be used for the prevention and/or treatment of Diabetes Typ 1 and 2, obesity, neuropathy and/or nephropathy.
    Type: Grant
    Filed: September 9, 2008
    Date of Patent: August 7, 2012
    Assignee: Merck Patent Gesellschaft mit Beschränkter Haftung
    Inventors: Lars Thore Burgdorf, Norbert Beier, Johannes Gleitz, Ulrich Emde, Christine Charon, Denis Carniato
  • Liquid-crystalline medium
    Patent number: 8236390
    Abstract: The invention relates to a liquid-crystalline medium based on a mixture of polar compounds, characterized in that it comprises one or more compounds of the formula I in which R1, X1, L1-5 have the meanings indicated in Claim 1, and to the use thereof for electro-optical purposes, in particular TN monitor applications.
    Type: Grant
    Filed: December 17, 2008
    Date of Patent: August 7, 2012
    Assignee: Merck Patent Gesellschaft mit beschränkter Haftung
    Inventors: Harald Hirschmann, Michael Wittek, Sabine Schoen
  • Liquid-crystalline medium and liquid-crystal display
    Patent number: 8231806
    Abstract: The present invention relates to dielectrically positive liquid-crystalline media comprising in each case one or more compounds of the formula I in which the parameters have the respective meanings indicated in the specification, and optionally one or more further dielectrically positive compounds and optionally one or more further dielectrically neutral compounds, and to liquid-crystal displays containing these media, especially to active-matrix displays and in particular to TN, IPS and FFS displays.
    Type: Grant
    Filed: February 25, 2009
    Date of Patent: July 31, 2012
    Assignee: Merck Patent Gesellschaft mit beschränkter Haftung
    Inventors: Markus Czanta, Michael Wittek, Lars Lietzau, Marcus Reuter, Brigitte Schuler
  • Benzimidazoledihydrothiadiazinone derivatives as fructose-1,6-bisphosphatase inhibitors, and pharmaceutical compositions comprising same
    Patent number: 8232272
    Abstract: The present invention relates to novel benzimidazole-dihydrothiadiazinone derivatives as fructose-1,6-bisphosphatase inhibitors, to processes for the preparation thereof and to the use thereof in therapy, especially for the treatment of diabetes.
    Type: Grant
    Filed: October 13, 2008
    Date of Patent: July 31, 2012
    Assignee: Merck Patent Gesellschaft mit beschränkter Haftung
    Inventors: Gerard Botton, Caroline Leriche, Annick Arbellot de Vacqueur, Annick Audet, Johannes Gleitz
  • POLYMERIZABLE COMPOUNDS AND THEIR USE IN LIQUID-CRYSTAL DISPLAYS
    Publication number: 20120182516
    Abstract: The present invention relates to polymerisable compounds, to processes and intermediates for the preparation thereof, and to the use thereof for optical, electro-optical and electronic purposes, in particular in liquid-crystal (LC) media and LC displays, especially in LC displays of the PS (“polymer sustained”) or PSA (“polymer sustained alignment”) type.
    Type: Application
    Filed: August 30, 2010
    Publication date: July 19, 2012
    Applicant: MERCK PATENT GESELLSCHAFT MIT BESCHRANKTER HAFTUNG
    Inventors: Andreas Taugerbeck, Achim Goetz
  • COMPONENTS FOR HIGH-FREQUENCY TECHNOLOGY, AND LIQUID-CRYSTALLINE MEDIA
    Publication number: 20120182200
    Abstract: The present invention relates to a component for high-frequency technology or for the microwave range and millimetre wave range of the electromagnetic spectrum, characterised in that it contains a liquid-crystal compound of the formula I in which the parameters have the respective meanings given in the claims or in the text, or a liquid-crystal medium which itself comprises one or more compounds of this formula I, and to the corresponding, novel liquid-crystal media, to the use and preparation thereof, and to the production and use of the components. The components according to the invention are particularly suitable as phase shifters in the microwave and millimetre wave range, for microwave and millimetre wave array antennae and very particularly for so-called tuneable reflectarrays.
    Type: Application
    Filed: September 14, 2010
    Publication date: July 19, 2012
    Applicant: MERCK PATENT GESELLSCHAFT MIT BESCHRANKTER HAFTUNG
    Inventors: Atsutaka Manabe, Mark Goebel, Dagmar Klass, Elvira Montenegro, Detlef Pauluth
  • INK JET PRINTABLE ETCHING INKS AND ASSOCIATED PROCESS
    Publication number: 20120181668
    Abstract: The present invention refers to a method for contactless deposition of new etching compositions onto surfaces of semiconductor devices as well as to the subsequent etching of functional layers being located on top of these semiconductor devices. Said functional layers may serve as surface passivation layers and/or anti-reflective coatings (ARCs).
    Type: Application
    Filed: August 20, 2010
    Publication date: July 19, 2012
    Applicant: MERCK PATENT GESELLSCHAFT MIT BESCHRANKTER HAFTUNG
    Inventors: Oliver Doll, Edward Plummer, Mark James, Ingo Koehler, Lana Nanson
  • Liquid crystalline medium and liquid crystal display
    Patent number: 8221854
    Abstract: The present invention relates to dielectrically positive liquid-crystalline media comprising a dielectrically positive component, component A, comprising a dielectrically positive compound of the formula I in which the parameters have the meaning indicated in the specification, and optionally a second dielectrically positive component, component B, comprising one or more dielectrically positive compounds having a dielectric anisotropy of great than 3, and optionally a dielectrically neutral component, component C, and to liquid-crystal displays containing these media, especially active-matrix displays and in particular TN, IPS and FFS displays.
    Type: Grant
    Filed: April 1, 2008
    Date of Patent: July 17, 2012
    Assignee: Merck Patent Gesellschaft MIT Beschränkter Haftung
    Inventors: Markus Czanta, Andreas Taugerbeck, Renate Bender, Lars Lietzau